{
    "balance": {
        "data": [
            "CONSOLIDATED BALANCE SHEETS\tDollars in Millions\t(UNAUDITED)\tASSETS\tSeptember 30,\t2019\tDecember 31,\t2018\tCurrent Assets:\tCash and cash equivalents\t$\t30,489\t$\t6,911\tMarketable securities\t2,053\t1,973\tReceivables\t5,510\t5,965\tInventories\t1,192\t1,195\tPrepaid expenses and other\t947\t1,116\tTotal Current Assets\t40,191\t17,160\tProperty, plant and equipment\t4,830\t5,027\tGoodwill\t6,513\t6,538\tOther intangible assets\t1,002\t1,091\tDeferred income taxes\t1,624\t1,371\tMarketable securities\t925\t1,775\tOther assets\t2,348\t2,024\tTotal Assets\t$\t57,433\t$\t34,986\tLIABILITIES\tCurrent Liabilities:\tShort-term debt obligations\t$\t569\t$\t1,703\tAccounts payable\t1,888\t1,892\tAccrued and other current liabilities\t8,032\t7,059\tTotal Current Liabilities\t10,489\t10,654\tIncome taxes payable\t2,919\t3,043\tOther non-current liabilities\t1,881\t1,516\tLong-term debt\t24,390\t5,646\tTotal Liabilities\t39,679\t20,859\tCommitments and contingencies\tEQUITY\tBristol-Myers Squibb Company Shareholders  Equity:\tPreferred stock\t \t \tCommon stock\t221\t221\tCapital in excess of par value of stock\t2,206\t2,081\tAccumulated other comprehensive loss\t(\t1,463\t)\t(\t2,762\t)\tRetained earnings\t36,555\t34,065\tLess cost of treasury stock\t(\t19,871\t)\t(\t19,574\t)\tTotal Bristol-Myers Squibb Company Shareholders  Equity\t17,648\t14,031\tNoncontrolling interest\t106\t96\tTotal Equity\t17,754\t14,127\tTotal Liabilities and Equity\t$\t57,433\t$\t34,986\tThe accompanying notes are an integral part of these consolidated financial statements.\t4\tBRISTOL-MYERS SQUIBB COMPANY\tCONSOLIDATED STATEMENTS OF CASH FLOWS\tDollars in Millions\t(UNAUDITED)\tNine Months Ended September 30,\t2019\t2018\tCash Flows From Operating Activities:\tNet earnings\t$\t4,520\t$\t3,789\tAdjustments to reconcile net earnings to net cash provided by operating activities:\tDepreciation and amortization, net\t510\t465\tDeferred income taxes\t(\t587\t)\t(\t161\t)\tStock-based compensation\t157\t168\tImpairment charges\t183\t110\tPension settlements and amortization\t1,683\t145\tDivestiture gains and royalties\t(\t1,676\t)\t(\t822\t)\tAsset acquisition charges\t25\t85\tEquity investment losses\t15\t244\tOther adjustments\t(\t21\t)\t(\t43\t)\tChanges in operating assets and liabilities:\tReceivables\t434\t(\t222\t)\tInventories\t(\t7\t)\t(\t152\t)\tAccounts payable\t48\t(\t186\t)\tDeferred income\t13\t84\tIncome taxes payable\t47\t199\tOther\t685\t(\t192\t)\tNet Cash Provided by Operating Activities\t6,029\t3,511\tCash Flows From Investing Activities:\tSale and maturities of marketable securities\t2,464\t1,453\tPurchase of marketable securities\t(\t1,642\t)\t(\t1,062\t)\tCapital expenditures\t(\t585\t)\t(\t661\t)\tDivestiture and other proceeds\t2,087\t947\tAcquisition and other payments\t(\t58\t)\t(\t1,215\t)\tNet Cash Provided by/(Used in) Investing Activities\t2,266\t(\t538\t)\tCash Flows From Financing Activities:\tShort-term debt obligations, net\t115\t(\t617\t)\tIssuance of long-term debt\t18,790\t \tRepayment of long-term debt\t(\t1,256\t)\t(\t5\t)\tRepurchase of common stock\t(\t300\t)\t(\t320\t)\tDividends\t(\t2,011\t)\t(\t1,960\t)\tOther\t(\t40\t)\t(\t55\t)\tNet Cash Provided by/(Used in) Financing Activities\t15,298\t(\t2,957\t)\tEffect of E"
        ],
        "timestamp": "2025-01-21_09-31-30"
    }
}